Study of endoscopic ultrasonography-guided Paclitaxel injection therapy for patients with pancreatic cystics lesion

Hara Kazuo0 个研究点目标入组 20 人开始时间: 2022年10月14日最近更新: 2023年10月17日

试验速览

暂无简介。

•1.Patients aged 20 years or older and 75 years or younger at the time of obtaining informed consent.
•2.Patients who given their written consent to participate in this study.
•3.Patients diagnosed with the pancreatic cystic lesion.
•4.Patients with cyst diameter of 10 mm or more and less than 50 mm measuring by CT or MRI.
•5.Patients with unilocular or oligolocular (4 or fewer locules) cyst morphology.
•6.Patients whose performance status are 0 to 1.
•7.Patients who are not indicated for surgery or refuse surgery in spite of having a certain degree of prognosis.

•1.Patients with a history of allergy to paclitaxel.
•2.Patients with cystic lesions obviously suspected of malignancy in the image findings.
•3.Patients with cystic lesions obviously suspected of pseudocyst or retention cyst in the image findings.
•4.The blood test results within 28 days before registration correspond to the following.
•(1)Prothrombin time <= 50% or international normalized ratio >= 1.5.
•(2)Platelet count <= 50000/mm3
•5.Patients taking 2 or more antithrombotic drugs.
•6.Patients who are pregnant or have possibility of pregnancy.
•7.Patients who are not expected to survive for at least 5 years.
•8.Patients who are deemed unsuitable for participating in this study for other reasons.

发起方

Hara Kazuo